← Back to news
Y

Yahoo Finance

Has Dutch Bros (BROS) Stock Been Good for Investors?

Y

Hedge fund manager compares MicroStrategy's Saylor to 'conman' Bankman-Fried

Y

What the end of the SAVE plan means for millions of student loan borrowers

Y

Seamless integration behind DP World rebrand of ocean container line

Y

Apollo CEO says some AI fortunes may be lost

Y

'The Idea That People Would Flee New York Was Overblown.' Rise In NYC Luxury Home Sales Show 'There Is No Mamdani Effect'

Y

Housing Optimism Helps the Dow

Y

How Can I Build a Low-Cost Portfolio Generating $10,000 Per Month In Dividends Without High Anxiety?

Y

How Fast Does an AI Chip Depreciate, and Why Does It Matter for Nvidia Stock?

Y

T-Bills Are Having Best Time of The Year. Here's Why.

Y

Crude Oil Prices Retreat on Concerns Over a Global Oil Glut

Y

2026 Comeback Picks: 3 S&P Laggards Poised to Break Out

Y

Treasuries Gain as Traders Hold to Rate-Cut Bets After Fed

Y

Lululemon CEO Calvin McDonald to step down in January

Y

Microsoft (MSFT) Announces $23 Billion Investment Plan, Morgan Stanley Reiterates “Buy” Rating

Y

Stifel Defends Marvell’s (MRVL) ASIC Leadership Amid AI Chip Market Rumors

Y

Arch Public co-founder says tokenization is 'just a talking point' now

Y

Vertiv (VRT) Cut to Peerperform as Wolfe Sees Balanced Risk-Reward

Y

Ondo, State Street, Galaxy Digital to Debut SWEEP Liquidity Fund in 2026

Y

HSBC Initiates Micron (MU) With Buy Rating and $330 Price Target

Y

Larry Ellison’s Oracle plunges as AI drive fails to pay off

Y

Legend Biotech Corporation (LEGN) is an Outperform on Multiple Myeloma Treatment CARVYKTI Prospects

Y

Is AbbVie Stock Too Cheap to Ignore at Today's Price?

Y

Is Ultragenyx Pharmaceutical (RARE) One of the Best Biotech Stocks to Buy According to Wall Street Analysts?

Y

This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street

Y

BNB Drops Below $865 as Crypto Market Moves Lower

Y

Citi Asserts Buy Rating on Summit Therapeutics Inc. (SMMT) on Pipeline Development

Y

SpaceX’s Lofty IPO Valuation Hinges on Big Bet on Outsize Growth

Y

UBS Reiterates Neutral on Apple (AAPL) as App Store Growth Slows

Y

Vaxcyte, Inc. (PCVX) Makes Strides on Pneumonia Treatment, Plots Coverage Extension

Y

Cross-Chain Liquidity Protocol LI.FI Raises $29M in Series A Extension

Y

Avocado and AI: How Would a New Model from Meta Platforms Influence the Bull and Bear Cases for META Stock?

Y

Cantor Sees AI Upside in Salesforce (CRM), Reiterates $325 Price Target

Y

Here’s How Quickly Oracle Is Ramping Up Capital Spending

Y

What most VCs won’t tell you about raising capital

Y

Broadcom, Oracle, Adobe: AI-Related Earnings in Spotlight

Y

Why Jerome Powell’s latest rate cut still won’t help you get a lower mortgage rate

Y

If You Want Retirement Income VYM Won’t Cut it, But These 3 ETFs Could

Y

Wall Street Firms Tout Corcept Therapeutics Incorporated (CORT) Prospects on Korlym Medication Prospects

Y

Crinetics Pharmaceuticals (CRNX) Poised for Transformational Growth in 2026: Piper Sandler

Y

Dow Jumps to New Highs as Fed Cut, Oracle Miss Fuel Shift from Tech to Value Stocks

Y

Needham Boosts Ciena (CIEN) Price Target to $240 Ahead of Earnings

Y

Bitcoin Stumbles Back Below $90K as Dollar Sinks to 7-Week Low After Fed Rate Cut

Y

Major automakers say China poses 'clear and present threat' to US auto industry

Y

2 Defined-Risk Options Strategies to Trade Quarterly Earnings Without Gambling

Y

As Democrats Sound the Alarm on Palantir, How Should You Play PLTR Stock?

Y

Ford and SK On are ending their US battery joint venture

Y

Chase Freedom Unlimited welcome offer: Earn $300 with a new card over the holidays

Y

This Stellar Vanguard ETF Is Beating the VTI and VOO This Year

Y

Oracle Slides by Most Since January on Mounting AI Spending

Y